Using antisense oligos to plumb rare genetic conditions, and more
Recent research highlights the use of antisense oligonucleotides (ASOs) to treat rare genetic conditions associated with autism, such as SCN2A variants and Bainbridge-Ropers syndrome. These studies suggest that targeted genetic therapies can improve motor and language skills in children.
Why it matters
Advancements in ASO technology offer a promising, personalized medical approach for treating complex, rare neurodevelopmental disorders that currently lack effective therapies.
Add us as a Preferred Source on Google Set us as a Preferred Source to see The Transmitter more prominently in your Google Search results. Using antisense oligos to plumb rare genetic conditions, and more Here is a roundup of autism-related news and research spotted around the web for the week of 3 August.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in